Secondary prevention of osteoporotic fractures in the Republic of Belarus: DALY-analysis and cost-effectiveness-Reference-Cited by-同舟云学术

Secondary prevention of osteoporotic fractures in the Republic of Belarus: DALY-analysis and cost-effectiveness

Published:2023-01-04 Issue:4 Volume:19 Page:120-127
ISSN:2708-6011
Container-title:Health and Ecology Issues
language:
Short-container-title:jour

Author:

Ramanau H. N.¹^ORCID,Rudenka E. V.^ORCID,Platoshkin E. N.¹^ORCID,Ramaniva A. A.²^ORCID

Affiliation:

1. Gomel State Medical University

2. Republican Research Center for Radiation Medicine and Human Ecology

Abstract

Objective. To calculate the number of lost (including healthy) years of life in patients aged 50 years and older with proximal femur fractures (PF) in the Republic of Belarus based on primary incidence data and evaluate the cost-effectiveness of the therapeutic model for the secondary prevention of osteoporotic fractures.Materials and methods. A comprehensive assessment of health losses was carried out using DALY analysis based on our own epidemiological data on the primary incidence of PF and is presented in years of life lost to due to premature mortality and the years lived with a disability. The alendronic acid (AA) prescription after a primary PF fracture was proposed for secondary prevention of PF fractures. The cost-effectiveness was calculated based on the cost of one saved (including healthy) year in relation to the national GDP per capita.Results. In the Republic of Belarus taking into account sex and age structure of the population it is expected to have a total of 2867 PF fractures in men (558 atal cases during the first year) and 7921 (2382 fatal cases) in women per year. The total number of lost (including healthy) years of life due to osteoporotic PF fractures was 8719.0 in men and 8169.9 in women. The administration of AA after PF fracture will save 1806.11 years of healthy life. The cost of one saved (incl. healthy) year was 1044.2 BYN/year for men (6.5% of GDP per capita) and 1720.1 BYN/year for women (10.8% of GDP per capita).Conclusion. Prescription of antiresorptive therapy in the form of alendronic acid to men and women aged 50 years and older after a osteoporotic PF fracture for prevention of recurrent osteoporotic fractures is highly cost-effective and can be considered when assessing the threshold of intervention in treating patients with osteoporosis in the Republic of Belarus.

Publisher

Gomel State Medical University

Reference15 articles.

1. Lesnyak ОМ, Baranova IА, Belova КY. Osteoporosis in the Russian Federation: epidemiology, medical, social and economic aspects of the problem (literature review). Traumatology and orthopedics of Russia. 2018;24(1):155-168. (in Russ.).

2. Ramanau H, Chernyanin I, Rudenka E, Lesnyak O, Zakroyeva A, Bilezikian JP, Johansson H, Harvey NC, McCloskey EV, Kanis JA. Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models. Arch Osteoporos. 2018 Apr 17;13(1):42. DOI: https://doi.org/10.1007/s11657-018-0454-4

3. Половозрастная структура населения Республики Беларусь на 1 января 2021 г. и среднегодовая численность населения за 2020 год. Statistical book [Electronic resource]. Minsk; 2018. [Date of access 2022 Sept 19]. Available from: https://www. belstat.gov.by/upload/iblock/5d5/5d516d1d43fb51a3c99498e5bf e616e3.pdf (in Russ.).

4. Schroeder SA. Incidence, prevalence, and hybrid approaches to calculating disability-adjusted life years. Popul Health Metr. 2012 Sep 12;10(1):19. DOI: https://doi.org/10.1186/1478-7954-10-19

5. Methodology for a comprehensive assessment of health losses as a result of morbidity and mortality. Instructions for use: approved. Ministry of Health of the Republic of Belarus 26.06.2006, No 140-1105. Minsk; 28 p. [Date of access 2022 Aug 19]. Available from: http://m.med.by/methods/pdf/140-1105.pdf (in Russ.).